6.60 -0.02 (-0.30%)
After hours: 4:43PM EDT
|Bid||6.60 x 1100|
|Ask||6.62 x 900|
|Day's Range||6.38 - 6.68|
|52 Week Range||4.00 - 17.86|
|Beta (5Y Monthly)||2.04|
|PE Ratio (TTM)||2.44|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
As of late, it has definitely been a great time to be an investor in Cronos Group.
Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) is a pot stock that trades at a big discount to its cash balance. Now is the time to strike.The post Turn $1,000 Into $4,000 With This Pot Stock appeared first on The Motley Fool Canada.
Is Cronos stock a buy right now?The post If You Invested $1,000 in Cronos IPO, You Would Have Returned a Staggering $85,000 Today appeared first on The Motley Fool Canada.
Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. You might think that after this huge gain, Aurora is outperforming rival Cronos Group (NASDAQ: CRON), which posted Q1 results earlier this month that were below expectations. Which of these two marijuana stocks is the better pick going forward?
The stock of Cronos Group (NASDAQ: CRON) ended the week on a high note, rising more than 8% on Friday to outpace the gains of the broader market. Cronos has a major CBD asset in its Lord Jones product line. Although the results of the study, conducted by researchers at the University of Lethbridge in Canada, were published last month, they are only now hitting the news media and getting on the radar of investors.
Colorado Representative Ed Perlmutter joins Yahoo Finance’s Zack Guzman to discuss the future of cannabis in the U.S., along with his outlook on future stimulus legislation.
Cronos Group Inc (TSX:CRON)(NASDAQ:CRON) stock is suffering during the coronavirus bear market. Could Altria Group (NYSE:MO) buy the company?The post Will Altria Buy Out Cronos (TSX:CRON) Stock? appeared first on The Motley Fool Canada.
Cannabis investors sometimes have to take earnings results with a grain of salt. Relying just on sales and net income figures can lead to incorrect conclusions. Cronos has recorded a positive net income figure in each of its past five quarterly results.
Shares of several top Canadian cannabis producers soared today after one of their peers, Aurora Cannabis (NYSE: ACB), reported better-than-expected fiscal 2020 third-quarter revenue growth after the market closed on Thursday. Canopy Growth (NYSE: CGC) stock was up 13.4% as of 3:38 p.m. EDT on Friday, while shares of Cronos Group (NASDAQ: CRON) and OrganiGram Holdings (NASDAQ: OGI) were up 10.3% and 13.5%, respectively. Investors now appear to be increasingly optimistic that the rest of the Canadian cannabis industry could also enjoy a turn for the better after a challenging period following Aurora's surprisingly positive results.
For years, the marijuana industry was the hottest investment on Wall Street. Over the past 13-plus months, cannabis stocks have been raked over the coals. Regulatory-based supply issues in Canada, high tax rates on legal-channel pot products in key U.S. states, and the inability of many North American pot stocks to access traditional forms of financing have quickly pulled the rug out from beneath this blazing hot industry.
Over the last 20 months, they have been impacted by valuation issues, a thriving black market, lower than expected demand, high inventory levels, mounting losses, health issues from the vaping scandals, and much more. The investor euphoria that surrounded cannabis stocks when Canada legalized marijuana for recreational use seems like a distant dream. The marijuana sector is still at a nascent stage and is expected to grow at a rapid pace in the upcoming decade.
Thank you, Natalia and thank you for joining us today to review Cronos Group's first quarter 2020 financial and business performance. Today, I'm joined by our Chairman, President and CEO, Mike Gorenstein; our CFO, Jerry Barbato and our EVP of Legal and Regulatory Affairs, Xiuming Shum. Cronos Group issued a news release announcing our financial results this morning, which are filed on our EDGAR and SEDAR profiles.
Cronos Group expects Canada’s cannabis market will be “choppy” for the next six months to a year as COVID-19 impacts sales channels.
Cronos (CRON) delivered earnings and revenue surprises of 385.71% and -21.68%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Over the past 13 months, the marijuana industry has done a 180 -- and not the good kind. Following a first quarter in 2019 that saw more than a dozen pot stocks gain at least 70%, the past 13 months have featured across-the-board declines for North American cannabis stocks of 50% to 95%. Meanwhile, in the U.S., high tax rates on legal cannabis have made it virtually impossible for retailers to compete with the black market.
Cronos (CRON) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
With the global economy withering under the COVID-19 pandemic, the odds of a wave of bankruptcies wiping out underperforming cannabis firms are on the rise.
Cannabis investors are battling a difficult bear market, but conditions could change quickly for stocks like Cronos Group Inc (TSX:CRON)(NASDAQ:CRON).The post Cannabis Investors: Expect a Bull Market in 2020 appeared first on The Motley Fool Canada.